 | • レポートコード：MRC2312MG03124 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、125ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の乳房生検ガイダンスシステム市場規模と予測を収録しています。・世界の乳房生検ガイダンスシステム市場：売上、2018年-2023年、2024年-2029年 ・世界の乳房生検ガイダンスシステム市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の乳房生検ガイダンスシステム市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「針乳房生検」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 乳房生検ガイダンスシステムのグローバル主要企業は、Hologic、 Danaher、 BD、 Argon Medical Devices、 Merit Medical Systems、 Menarini-Silicon Biosystems、 Guardant Health、 NeoGenomics、 Sysmex Inostics、 Sterylab、 Biocept、 Bio-Rad Laboratories、 Roche、 Qiagen、 Exact Sciences、 Thermo Fisher Scientific、 Cardiff Oncology、 Myriad Genetics、 Illumina、 Fluxion Biosciences、 Fujifilm、 Inrad、 IZI Medical Products、 Remington Medical、 CP Medicalなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、乳房生検ガイダンスシステムのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の乳房生検ガイダンスシステム市場：タイプ別、2018年-2023年、2024年-2029年 世界の乳房生検ガイダンスシステム市場：タイプ別市場シェア、2022年 ・針乳房生検、開胸手術乳房生検、液体乳房生検 世界の乳房生検ガイダンスシステム市場：用途別、2018年-2023年、2024年-2029年 世界の乳房生検ガイダンスシステム市場：用途別市場シェア、2022年 ・病院、研究所、その他 世界の乳房生検ガイダンスシステム市場：地域・国別、2018年-2023年、2024年-2029年 世界の乳房生検ガイダンスシステム市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における乳房生検ガイダンスシステムのグローバル売上、2018年-2023年 ・主要企業における乳房生検ガイダンスシステムのグローバル売上シェア、2022年 ・主要企業における乳房生検ガイダンスシステムのグローバル販売量、2018年-2023年 ・主要企業における乳房生検ガイダンスシステムのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Hologic、 Danaher、 BD、 Argon Medical Devices、 Merit Medical Systems、 Menarini-Silicon Biosystems、 Guardant Health、 NeoGenomics、 Sysmex Inostics、 Sterylab、 Biocept、 Bio-Rad Laboratories、 Roche、 Qiagen、 Exact Sciences、 Thermo Fisher Scientific、 Cardiff Oncology、 Myriad Genetics、 Illumina、 Fluxion Biosciences、 Fujifilm、 Inrad、 IZI Medical Products、 Remington Medical、 CP Medical ************************************************************* ・調査・分析レポートの概要 乳房生検ガイダンスシステム市場の定義 市場セグメント 世界の乳房生検ガイダンスシステム市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の乳房生検ガイダンスシステム市場規模 世界の乳房生検ガイダンスシステム市場規模：2022年 VS 2029年 世界の乳房生検ガイダンスシステム市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの乳房生検ガイダンスシステムの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の乳房生検ガイダンスシステム製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：針乳房生検、開胸手術乳房生検、液体乳房生検 乳房生検ガイダンスシステムのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、研究所、その他 乳房生検ガイダンスシステムの用途別グローバル売上・予測 ・地域別市場分析 地域別乳房生検ガイダンスシステム市場規模 2022年と2029年 地域別乳房生検ガイダンスシステム売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Hologic、 Danaher、 BD、 Argon Medical Devices、 Merit Medical Systems、 Menarini-Silicon Biosystems、 Guardant Health、 NeoGenomics、 Sysmex Inostics、 Sterylab、 Biocept、 Bio-Rad Laboratories、 Roche、 Qiagen、 Exact Sciences、 Thermo Fisher Scientific、 Cardiff Oncology、 Myriad Genetics、 Illumina、 Fluxion Biosciences、 Fujifilm、 Inrad、 IZI Medical Products、 Remington Medical、 CP Medical ... |
This research report provides a comprehensive analysis of the Breast Biopsy Guidance System market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Breast Biopsy Guidance System market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Breast Biopsy Guidance System, challenges faced by the industry, and potential opportunities for market players.
The global Breast Biopsy Guidance System market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Breast Biopsy Guidance System market presents opportunities for various stakeholders, including Hospital, Laboratory. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Breast Biopsy Guidance System market. Additionally, the growing consumer demand present avenues for market expansion.
The global Breast Biopsy Guidance System market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Key Features:
The research report on the Breast Biopsy Guidance System market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Breast Biopsy Guidance System market.
Market Overview: The report provides a comprehensive overview of the Breast Biopsy Guidance System market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Needle Breast Biopsy, Open Surgical Breast Biopsy）, region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Breast Biopsy Guidance System market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Breast Biopsy Guidance System market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Breast Biopsy Guidance System market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Breast Biopsy Guidance System market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Breast Biopsy Guidance System market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Breast Biopsy Guidance System market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Breast Biopsy Guidance System, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Breast Biopsy Guidance System market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Breast Biopsy Guidance System market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Needle Breast Biopsy
Open Surgical Breast Biopsy
Liquid Breast Biopsy
Market segment by Application
Hospital
Laboratory
Others
Global Breast Biopsy Guidance System Market Segment Percentages, By Region and Country, 2022 (%）
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Hologic
Danaher
BD
Argon Medical Devices
Merit Medical Systems
Menarini-Silicon Biosystems
Guardant Health
NeoGenomics
Sysmex Inostics
Sterylab
Biocept
Bio-Rad Laboratories
Roche
Qiagen
Exact Sciences
Thermo Fisher Scientific
Cardiff Oncology
Myriad Genetics
Illumina
Fluxion Biosciences
Fujifilm
Inrad
IZI Medical Products
Remington Medical
CP Medical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Breast Biopsy Guidance System, market overview.
Chapter 2: Global Breast Biopsy Guidance System market size in revenue and volume.
Chapter 3: Detailed analysis of Breast Biopsy Guidance System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Breast Biopsy Guidance System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Breast Biopsy Guidance System capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Breast Biopsy Guidance System Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Breast Biopsy Guidance System Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Breast Biopsy Guidance System Overall Market Size
2.1 Global Breast Biopsy Guidance System Market Size: 2022 VS 2029
2.2 Global Breast Biopsy Guidance System Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Breast Biopsy Guidance System Sales: 2018-2029
3 Company Landscape
3.1 Top Breast Biopsy Guidance System Players in Global Market
3.2 Top Global Breast Biopsy Guidance System Companies Ranked by Revenue
3.3 Global Breast Biopsy Guidance System Revenue by Companies
3.4 Global Breast Biopsy Guidance System Sales by Companies
3.5 Global Breast Biopsy Guidance System Price by Manufacturer (2018-2023）
3.6 Top 3 and Top 5 Breast Biopsy Guidance System Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Breast Biopsy Guidance System Product Type
3.8 Tier 1, Tier 2 and Tier 3 Breast Biopsy Guidance System Players in Global Market
3.8.1 List of Global Tier 1 Breast Biopsy Guidance System Companies
3.8.2 List of Global Tier 2 and Tier 3 Breast Biopsy Guidance System Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Breast Biopsy Guidance System Market Size Markets, 2022 & 2029
4.1.2 Needle Breast Biopsy
4.1.3 Open Surgical Breast Biopsy
4.1.4 Liquid Breast Biopsy
4.2 By Type – Global Breast Biopsy Guidance System Revenue & Forecasts
4.2.1 By Type – Global Breast Biopsy Guidance System Revenue, 2018-2023
4.2.2 By Type – Global Breast Biopsy Guidance System Revenue, 2024-2029
4.2.3 By Type – Global Breast Biopsy Guidance System Revenue Market Share, 2018-2029
4.3 By Type – Global Breast Biopsy Guidance System Sales & Forecasts
4.3.1 By Type – Global Breast Biopsy Guidance System Sales, 2018-2023
4.3.2 By Type – Global Breast Biopsy Guidance System Sales, 2024-2029
4.3.3 By Type – Global Breast Biopsy Guidance System Sales Market Share, 2018-2029
4.4 By Type – Global Breast Biopsy Guidance System Price (Manufacturers Selling Prices）, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Breast Biopsy Guidance System Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Laboratory
5.1.4 Others
5.2 By Application – Global Breast Biopsy Guidance System Revenue & Forecasts
5.2.1 By Application – Global Breast Biopsy Guidance System Revenue, 2018-2023
5.2.2 By Application – Global Breast Biopsy Guidance System Revenue, 2024-2029
5.2.3 By Application – Global Breast Biopsy Guidance System Revenue Market Share, 2018-2029
5.3 By Application – Global Breast Biopsy Guidance System Sales & Forecasts
5.3.1 By Application – Global Breast Biopsy Guidance System Sales, 2018-2023
5.3.2 By Application – Global Breast Biopsy Guidance System Sales, 2024-2029
5.3.3 By Application – Global Breast Biopsy Guidance System Sales Market Share, 2018-2029
5.4 By Application – Global Breast Biopsy Guidance System Price (Manufacturers Selling Prices）, 2018-2029
6 Sights by Region
6.1 By Region – Global Breast Biopsy Guidance System Market Size, 2022 & 2029
6.2 By Region – Global Breast Biopsy Guidance System Revenue & Forecasts
6.2.1 By Region – Global Breast Biopsy Guidance System Revenue, 2018-2023
6.2.2 By Region – Global Breast Biopsy Guidance System Revenue, 2024-2029
6.2.3 By Region – Global Breast Biopsy Guidance System Revenue Market Share, 2018-2029
6.3 By Region – Global Breast Biopsy Guidance System Sales & Forecasts
6.3.1 By Region – Global Breast Biopsy Guidance System Sales, 2018-2023
6.3.2 By Region – Global Breast Biopsy Guidance System Sales, 2024-2029
6.3.3 By Region – Global Breast Biopsy Guidance System Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Breast Biopsy Guidance System Revenue, 2018-2029
6.4.2 By Country – North America Breast Biopsy Guidance System Sales, 2018-2029
6.4.3 US Breast Biopsy Guidance System Market Size, 2018-2029
6.4.4 Canada Breast Biopsy Guidance System Market Size, 2018-2029
6.4.5 Mexico Breast Biopsy Guidance System Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Breast Biopsy Guidance System Revenue, 2018-2029
6.5.2 By Country – Europe Breast Biopsy Guidance System Sales, 2018-2029
6.5.3 Germany Breast Biopsy Guidance System Market Size, 2018-2029
6.5.4 France Breast Biopsy Guidance System Market Size, 2018-2029
6.5.5 U.K. Breast Biopsy Guidance System Market Size, 2018-2029
6.5.6 Italy Breast Biopsy Guidance System Market Size, 2018-2029
6.5.7 Russia Breast Biopsy Guidance System Market Size, 2018-2029
6.5.8 Nordic Countries Breast Biopsy Guidance System Market Size, 2018-2029
6.5.9 Benelux Breast Biopsy Guidance System Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Breast Biopsy Guidance System Revenue, 2018-2029
6.6.2 By Region – Asia Breast Biopsy Guidance System Sales, 2018-2029
6.6.3 China Breast Biopsy Guidance System Market Size, 2018-2029
6.6.4 Japan Breast Biopsy Guidance System Market Size, 2018-2029
6.6.5 South Korea Breast Biopsy Guidance System Market Size, 2018-2029
6.6.6 Southeast Asia Breast Biopsy Guidance System Market Size, 2018-2029
6.6.7 India Breast Biopsy Guidance System Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Breast Biopsy Guidance System Revenue, 2018-2029
6.7.2 By Country – South America Breast Biopsy Guidance System Sales, 2018-2029
6.7.3 Brazil Breast Biopsy Guidance System Market Size, 2018-2029
6.7.4 Argentina Breast Biopsy Guidance System Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Breast Biopsy Guidance System Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Breast Biopsy Guidance System Sales, 2018-2029
6.8.3 Turkey Breast Biopsy Guidance System Market Size, 2018-2029
6.8.4 Israel Breast Biopsy Guidance System Market Size, 2018-2029
6.8.5 Saudi Arabia Breast Biopsy Guidance System Market Size, 2018-2029
6.8.6 UAE Breast Biopsy Guidance System Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Hologic
7.1.1 Hologic Company Summary
7.1.2 Hologic Business Overview
7.1.3 Hologic Breast Biopsy Guidance System Major Product Offerings
7.1.4 Hologic Breast Biopsy Guidance System Sales and Revenue in Global (2018-2023）
7.1.5 Hologic Key News & Latest Developments
7.2 Danaher
7.2.1 Danaher Company Summary
7.2.2 Danaher Business Overview
7.2.3 Danaher Breast Biopsy Guidance System Major Product Offerings
7.2.4 Danaher Breast Biopsy Guidance System Sales and Revenue in Global (2018-2023）
7.2.5 Danaher Key News & Latest Developments
7.3 BD
7.3.1 BD Company Summary
7.3.2 BD Business Overview
7.3.3 BD Breast Biopsy Guidance System Major Product Offerings
7.3.4 BD Breast Biopsy Guidance System Sales and Revenue in Global (2018-2023）
7.3.5 BD Key News & Latest Developments
7.4 Argon Medical Devices
7.4.1 Argon Medical Devices Company Summary
7.4.2 Argon Medical Devices Business Overview
7.4.3 Argon Medical Devices Breast Biopsy Guidance System Major Product Offerings
7.4.4 Argon Medical Devices Breast Biopsy Guidance System Sales and Revenue in Global (2018-2023）
7.4.5 Argon Medical Devices Key News & Latest Developments
7.5 Merit Medical Systems
7.5.1 Merit Medical Systems Company Summary
7.5.2 Merit Medical Systems Business Overview
7.5.3 Merit Medical Systems Breast Biopsy Guidance System Major Product Offerings
7.5.4 Merit Medical Systems Breast Biopsy Guidance System Sales and Revenue in Global (2018-2023）
7.5.5 Merit Medical Systems Key News & Latest Developments
7.6 Menarini-Silicon Biosystems
7.6.1 Menarini-Silicon Biosystems Company Summary
7.6.2 Menarini-Silicon Biosystems Business Overview
7.6.3 Menarini-Silicon Biosystems Breast Biopsy Guidance System Major Product Offerings
7.6.4 Menarini-Silicon Biosystems Breast Biopsy Guidance System Sales and Revenue in Global (2018-2023）
7.6.5 Menarini-Silicon Biosystems Key News & Latest Developments
7.7 Guardant Health
7.7.1 Guardant Health Company Summary
7.7.2 Guardant Health Business Overview
7.7.3 Guardant Health Breast Biopsy Guidance System Major Product Offerings
7.7.4 Guardant Health Breast Biopsy Guidance System Sales and Revenue in Global (2018-2023）
7.7.5 Guardant Health Key News & Latest Developments
7.8 NeoGenomics
7.8.1 NeoGenomics Company Summary
7.8.2 NeoGenomics Business Overview
7.8.3 NeoGenomics Breast Biopsy Guidance System Major Product Offerings
7.8.4 NeoGenomics Breast Biopsy Guidance System Sales and Revenue in Global (2018-2023）
7.8.5 NeoGenomics Key News & Latest Developments
7.9 Sysmex Inostics
7.9.1 Sysmex Inostics Company Summary
7.9.2 Sysmex Inostics Business Overview
7.9.3 Sysmex Inostics Breast Biopsy Guidance System Major Product Offerings
7.9.4 Sysmex Inostics Breast Biopsy Guidance System Sales and Revenue in Global (2018-2023）
7.9.5 Sysmex Inostics Key News & Latest Developments
7.10 Sterylab
7.10.1 Sterylab Company Summary
7.10.2 Sterylab Business Overview
7.10.3 Sterylab Breast Biopsy Guidance System Major Product Offerings
7.10.4 Sterylab Breast Biopsy Guidance System Sales and Revenue in Global (2018-2023）
7.10.5 Sterylab Key News & Latest Developments
7.11 Biocept
7.11.1 Biocept Company Summary
7.11.2 Biocept Business Overview
7.11.3 Biocept Breast Biopsy Guidance System Major Product Offerings
7.11.4 Biocept Breast Biopsy Guidance System Sales and Revenue in Global (2018-2023）
7.11.5 Biocept Key News & Latest Developments
7.12 Bio-Rad Laboratories
7.12.1 Bio-Rad Laboratories Company Summary
7.12.2 Bio-Rad Laboratories Business Overview
7.12.3 Bio-Rad Laboratories Breast Biopsy Guidance System Major Product Offerings
7.12.4 Bio-Rad Laboratories Breast Biopsy Guidance System Sales and Revenue in Global (2018-2023）
7.12.5 Bio-Rad Laboratories Key News & Latest Developments
7.13 Roche
7.13.1 Roche Company Summary
7.13.2 Roche Business Overview
7.13.3 Roche Breast Biopsy Guidance System Major Product Offerings
7.13.4 Roche Breast Biopsy Guidance System Sales and Revenue in Global (2018-2023）
7.13.5 Roche Key News & Latest Developments
7.14 Qiagen
7.14.1 Qiagen Company Summary
7.14.2 Qiagen Business Overview
7.14.3 Qiagen Breast Biopsy Guidance System Major Product Offerings
7.14.4 Qiagen Breast Biopsy Guidance System Sales and Revenue in Global (2018-2023）
7.14.5 Qiagen Key News & Latest Developments
7.15 Exact Sciences
7.15.1 Exact Sciences Company Summary
7.15.2 Exact Sciences Business Overview
7.15.3 Exact Sciences Breast Biopsy Guidance System Major Product Offerings
7.15.4 Exact Sciences Breast Biopsy Guidance System Sales and Revenue in Global (2018-2023）
7.15.5 Exact Sciences Key News & Latest Developments
7.16 Thermo Fisher Scientific
7.16.1 Thermo Fisher Scientific Company Summary
7.16.2 Thermo Fisher Scientific Business Overview
7.16.3 Thermo Fisher Scientific Breast Biopsy Guidance System Major Product Offerings
7.16.4 Thermo Fisher Scientific Breast Biopsy Guidance System Sales and Revenue in Global (2018-2023）
7.16.5 Thermo Fisher Scientific Key News & Latest Developments
7.17 Cardiff Oncology
7.17.1 Cardiff Oncology Company Summary
7.17.2 Cardiff Oncology Business Overview
7.17.3 Cardiff Oncology Breast Biopsy Guidance System Major Product Offerings
7.17.4 Cardiff Oncology Breast Biopsy Guidance System Sales and Revenue in Global (2018-2023）
7.17.5 Cardiff Oncology Key News & Latest Developments
7.18 Myriad Genetics
7.18.1 Myriad Genetics Company Summary
7.18.2 Myriad Genetics Business Overview
7.18.3 Myriad Genetics Breast Biopsy Guidance System Major Product Offerings
7.18.4 Myriad Genetics Breast Biopsy Guidance System Sales and Revenue in Global (2018-2023）
7.18.5 Myriad Genetics Key News & Latest Developments
7.19 Illumina
7.19.1 Illumina Company Summary
7.19.2 Illumina Business Overview
7.19.3 Illumina Breast Biopsy Guidance System Major Product Offerings
7.19.4 Illumina Breast Biopsy Guidance System Sales and Revenue in Global (2018-2023）
7.19.5 Illumina Key News & Latest Developments
7.20 Fluxion Biosciences
7.20.1 Fluxion Biosciences Company Summary
7.20.2 Fluxion Biosciences Business Overview
7.20.3 Fluxion Biosciences Breast Biopsy Guidance System Major Product Offerings
7.20.4 Fluxion Biosciences Breast Biopsy Guidance System Sales and Revenue in Global (2018-2023）
7.20.5 Fluxion Biosciences Key News & Latest Developments
7.21 Fujifilm
7.21.1 Fujifilm Company Summary
7.21.2 Fujifilm Business Overview
7.21.3 Fujifilm Breast Biopsy Guidance System Major Product Offerings
7.21.4 Fujifilm Breast Biopsy Guidance System Sales and Revenue in Global (2018-2023）
7.21.5 Fujifilm Key News & Latest Developments
7.22 Inrad
7.22.1 Inrad Company Summary
7.22.2 Inrad Business Overview
7.22.3 Inrad Breast Biopsy Guidance System Major Product Offerings
7.22.4 Inrad Breast Biopsy Guidance System Sales and Revenue in Global (2018-2023）
7.22.5 Inrad Key News & Latest Developments
7.23 IZI Medical Products
7.23.1 IZI Medical Products Company Summary
7.23.2 IZI Medical Products Business Overview
7.23.3 IZI Medical Products Breast Biopsy Guidance System Major Product Offerings
7.23.4 IZI Medical Products Breast Biopsy Guidance System Sales and Revenue in Global (2018-2023）
7.23.5 IZI Medical Products Key News & Latest Developments
7.24 Remington Medical
7.24.1 Remington Medical Company Summary
7.24.2 Remington Medical Business Overview
7.24.3 Remington Medical Breast Biopsy Guidance System Major Product Offerings
7.24.4 Remington Medical Breast Biopsy Guidance System Sales and Revenue in Global (2018-2023）
7.24.5 Remington Medical Key News & Latest Developments
7.25 CP Medical
7.25.1 CP Medical Company Summary
7.25.2 CP Medical Business Overview
7.25.3 CP Medical Breast Biopsy Guidance System Major Product Offerings
7.25.4 CP Medical Breast Biopsy Guidance System Sales and Revenue in Global (2018-2023）
7.25.5 CP Medical Key News & Latest Developments
8 Global Breast Biopsy Guidance System Production Capacity, Analysis
8.1 Global Breast Biopsy Guidance System Production Capacity, 2018-2029
8.2 Breast Biopsy Guidance System Production Capacity of Key Manufacturers in Global Market
8.3 Global Breast Biopsy Guidance System Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Breast Biopsy Guidance System Supply Chain Analysis
10.1 Breast Biopsy Guidance System Industry Value Chain
10.2 Breast Biopsy Guidance System Upstream Market
10.3 Breast Biopsy Guidance System Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Breast Biopsy Guidance System Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
